Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?-Reference-Cited by-同舟云学术

Early Versus Deferred Cystectomy for Initial High-Risk pT1G3 Urothelial Carcinoma of the Bladder: Do Risk Factors Define Feasibility of Bladder-Sparing Approach?

Published:2008-01 Issue:1 Volume:53 Page:146-152
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Denzinger Stefan,Fritsche Hans-Martin,Otto Wolfgang,Blana Andreas,Wieland Wolf-Ferdinand,Burger Maximilian

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Contemporary management of stage T1 transitional cell carcinoma of the bladder;Soloway;J Urol,2002

2. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal;Cheng;Cancer,1999

3. The biological characteristics of pT1G3 bladder tumours are the same as muscle invasive cancer: a study of cell proliferation and molecular markers of aggressiveness;Sriprasad;J Urol,2001

4. Should bladder biopsies be performed routinely after bacillus Calmette-Guérin treatment for high-risk superficial transitional cell cancer of the bladder?;Guy;Eur Urol,2006

5. The value of a second transurethral resection for T1 bladder cancer;Schwaibold;BJU Int,2006

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?;Clinical Genitourinary Cancer;2023-12

2. Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy;European Urology Oncology;2023-12

3. The prediction of cancer-specific mortality in T1 non-muscle-invasive bladder cancer: comparison of logistic regression and artificial neural network: a SEER population-based study;International Urology and Nephrology;2023-06-06

4. Identifying novel biomarkers associated with bladder cancer treatment outcomes;Frontiers in Oncology;2023-03-29

5. Pushing the Envelope: The Role of Radiation Therapy in Non-muscle-Invasive Bladder Cancer;Seminars in Radiation Oncology;2023-01